Citations

Clear

626 citation(s) found for "Mehta, SH".

Abstract 17804: Prediabetes and Stroke Risk in Hospitalized Non-Diabetic Geriatric Patients With Atrial Fibrillation: Unfurling the Association Through Population-Based Analysis
Sampath, Shrikanth , Srivastava, Archit , Suchday, Pooja , Bhanushali, Aditi K, Behera, Alkananda , MEHTA, KAMYA, Eppalapally, Akhil kumar, Bollampalli, Ram Prasanjith Reddy, Desai, Rupak

Mayo Clinic

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.17804 Get It

Background: The association of prediabetes (pDM) with stroke risk in non-diabetic geriatric patients with AF is unclear. The findings from this analysis contribute to a better understanding of the interrelation between pDM, AF, and stroke, highlighting the need for targeted interventions and risk management strategies in this vulnerable population. Methods: Utilizing the 2019 National Inpatient Sample and employing ICD-10 CM coding, we identified all non-diabetic geriatric admissions with AF. Patients were categorized into two groups: pDM+ and pDM-. The primary outcomes of interest were stroke incidence, odds and potential sex disparities in odds as a risk factor for stroke in geriatric patients with AF. Results: Of the total 218130 non-diabetic geriatric AF admissions, 3525(1.6%) had pDM. The pDM+ cohort was relatively younger (median 75 vs 77 years), and often consisted of females (57.9%; p<0.359), white (80.1%), and from the higher-income quartile (28.5%); (p<0.001). The preDM+ group had significantly higher rates of complicated HTN (50.2 vs 43.6%), hyperlipidemia (66.4 vs 53.7%), obesity (30.2 vs 13.6%), PVD (15.3 vs 9.9%), stroke (1.4 vs 0.8%). After adjusting for baseline characteristics/comorbidities, the pDM+ cohort with AF admissions showed a higher rate and significantly higher odds of stroke vs the pDM- cohort (1.4% vs. 0.8%, OR 2.00, 95%CI 1.06-3.77; p=0.033). On subgroup analyses, males had a stronger association (OR 5.48, 95%CI 1.43-21.02; p=0.013) vs. females. Conclusion: Our research revealed that geriatric patients hospitalized with AF who had concomitant pDM were twice likely to develop stroke, with male preponderance. Further research is warranted to develop tailored interventions to mitigate the risk of stroke in AF patients with pDM.
Abstract 16010: Sudden Death in the Systemic Right Ventricle: Single Center Study of Dextro-Transposition of the Great Arteries Palliated With Atrial Switch
Ahmad, Rimsha , Chiriac, Anca , Bhalla, Jaideep Singh , Mehta, Ramila A. , Connolly, Heidi M. , Egbe, Alexander C. , Nguyen, Duy T. , Madhavan, Malini , McLeod, Christopher J. , Asirvatham, Samuel J.

Mayo Clinic

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.16010 Get It

Introduction: The incidence and risk factors for sudden cardiac death (SCD) in patients with systemic right ventricle (sRV) and D-TGA palliated with atrial switch procedures is not well understood. Methods: This cohort was examined retrospectively for the composite end point of SCD, sustained ventricular tachycardia (VT) >30 s or appropriate ICD therapy for VT. Clinical characteristics of those with and without the end point were compared using the Kruskal-Wallis or Chi-square test as appropriate. Results: The composite end point occurred in 15 of 148 (10%) patients (63.5% male) at a mean age of 36.4 (SD 10.3) years. SCD occurred in 6 patients (n=2 successfully resuscitated), sustained VT in 6 patients and ICD therapy for VT in 3 patients who had previously received a primary prevention ICD. Patients with SCD/VT had lower sRV ejection fraction (EF) compared to patients without SCD/VT [28±11 vs 40±10%, P<0.001]. The odds ratio of SCD/VT in patients with sRVEF≤35% compared to sRVEF>35% was 13.3 (95% CI 2.8 - 64.4). Kaplan Meier analysis of time to SCD/VT stratified by sRV EF is presented in figure. QRS duration, QRS fragmentation, QTc and history of systemic AV valve surgery were not significantly associated with SCD/VT. Non-sustained ventricular tachycardia (NSVT) on Holter monitoring occurred more frequently in SCD/VT patients (80 vs 39%, p=0.003). All 11 survivors of SCD/VT received an ICD; appropriate ICD therapy occurred in 27% of these patients during follow-up. Conclusion: SCD or VT occurred in one-tenth of D-TGA patients palliated with atrial switch, predominantly in 3 rd and 4 th decade of life. Reduced sRV EF was the most important association and ICD implantation for primary prevention of SCD is a reasonable consideration in those with reduced sRV EF.
Abstract 14177: Alarming Burden and Disparities of MACCE in Postmenopausal Women of a Contemporary Nationwide Cohort, 2020
Sampath, Shrikanth , Srivastava, Archit , Suchday, Pooja , Bhanushali, Aditi K, MEHTA, KAMYA, Behera, Alkananda , Eppalapally, Akhil kumar, Bollampalli, Ram Prasanjith Reddy, Desai, Rupak

Mayo Clinic

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.14177 Get It

Background: Cardiovascular disease is the leading cause of death worldwide, with a notable impact on postmenopausal women. However, contemporary large-scale population-based data for the burden and disparities of Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) in this population remains limited. Methods: The National Inpatient Sample (2020, ICD10 codes, age>55 years) was queried to identify postmenopausal women's hospitalizations. Socio-demographics, racial subgroups, comorbidities, and MACCE rates were retrieved with a more granular comparative analysis in postmenopausal women. A p<0.05 was considered statistically significant. Results: Of the total 8435195 postmenopausal women hospitalizations (median age 75 years), 1021375 (12.1%) were identified with MACCE. MACCE cohort, in comparison to non-MACCE cohort, had significantly higher prevalence of hypertension (77.1% vs 71.3), diabetes (39.8% vs 34.0%), hyperlipidemia (53.7% vs 48.4%), PVD (9.8% vs 7.1%), prior MI (8.3 vs 5.7%), prior TIA/stroke (10.5 vs 9%) and CKD (29.4 vs 23.4%). Significant clinical predictors for all-cause mortality were found to be race Asian/PI vs white ( 1.31 [1.09-1.18]), median household income national quartile (1.16 [1.13-1.20]), hypertension (1.18[1.16-1.20]) diabetes (1.20 [1.19-1.22]), hyperlipidemia (1.12[1.11-1.14]), prior MI (1.37[1.34-1.40]) and prior TIA stroke (1.0 5 [1.03-1.07] (all p<0.05). Conclusion: Among hospitalizations, Asian/Pacific Islanders, patients from the lowermost income quartile with co-existent hypertension, diabetes, hyperlipidemia, CKD, and cardiovascular comorbidities independently revealed the highest MACCE rates. Special emphasis needs to be laid on socio-demographics, comorbidities, and racial differences for CVD disease prevention, and risk factor modification in postmenopausal women.
Abstract 18539: The Impact of Prophylactic Heparin on Pocket Hematoma Formation After Cardiac Implantable Electronic Device Implantation a Real-World Experience
Patel, Harsh , Peters, Garrett , Mazimba, Sula , Deshmukh, Abhishek , Mehta, Nishaki, Agarwal, Siddharth , Agarwal, Siddharth , Kumar, Ashish , Agarwal, Siddharth

Mayo Clinic

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.18539 Get It

Introduction: Intravenous heparin is strongly associated with pocket hematoma (PH) formation in patients undergoing cardiac implantable electronic device (CIED) implantation. However, there is no data on subcutaneous prophylactic heparin in this population Hypothesis: We hypothesized that the subcutaneous heparin may increase the odds of PH in patients undergoing CIED implantation using data from a large, nationally representative sample of the US population. Methods: The Premier Healthcare Database was analyzed from 2016-2019 to identify patients >18 years old undergoing CIED implantation. Patients with PH were then identified by using ICD-10 CM codes. A multivariable logistic regression model was used to adjust for confounders Results: A total of 267,650 patients underwent CIED implantation between January 1, 2016, and December 31, 2019, of which 4,496 (1.68%) \developed PH. Single chamber pacemaker in 7.22%, dual-chamber pacemaker was implanted in 58.3% of patients, and CRT-P in 4.59%, ICD in 18.58%, CRT-D in 11.31%. Of the total cohort, 559 Patients received subcutaneous heparin within 3 days of the CIED implant procedure. Of these 559 patients, 91 (16%) patients were on subcutaneous heparin (pre-procedural: 19; post-procedural: 57) and developed PH. Subcutaneous heparin is associated with increased odds (OR :13.8,p<0.01) of PH formation. Conclusions: This study suggests that subcutaneous heparin is a strong risk factor for the development of PH. This may independently drive up the rates of PH in the inpatient population. Further studies on the timing of subcutaneous heparin need to be conducted.
Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations (S27.001)
Beach, Thomas G. , Zhang, Nan , Shill, Holly A. , Driver‐Dunckley, Erika , Caviness, John N., Mehta, Shyamal H. , Sue, Lucia I., Belden, Christine M. , Powell, Jessica, Jacobson, Sandra A. , Zamrini, Edward , Davis, Kathryn, Hentz, Joseph G. , Adler, Charles H. , Sabbagh, Marwan Noel , Serrano, Geidy E. , Shprecher, David , Dugger, Brittany N.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s27.001 Get It

Effects of ADS-5102 on non-motor symptoms (NMS) in Parkinson’s disease patients with dyskinesia (P1.039)
Mehta, Shyamal, Johnson, Reed, Llorens, Lily, Patni, Rajiv, Mehta, Shyamal H. , Pahwa, Rajesh , Tanner, Caroline M. , Hauser, Robert A.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p1.039 Get It

Towards Improved Diagnosis in Epilepsy (P1.035)
Yao, Robert, Csernak, Lidia, Salinas, Edgar, Okazaki, Erin, Sirven, Joseph I , Mehta, Neel

Mayo Clinic

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p1.035 Get It

The Neurologic Assessment in Neuro-Oncology (NANO) Scale: A Tool to Assess Neurologic Function for Integration in the Radiologic Assessment in Neuro-Oncology (RANO) Criteria (S22.005)
Nayak, Lakshmi , Wen, Patrick Y. , Chamberlain, Marc C. , MacDonald, David , Perry, James , Jaeckle, Kurt A. , Reardon, David A. , DeAngelis, Lisa M. , Wen, Patrick Yung , Brandes, Alba Ariela , Soffietti, Riccardo , Lin, Nancy U. , Peereboom, David M. , Galanis, Evanthia , Mehta, Minesh P. , Stupp, Roger , Bent, Martin J. van den

Mayo Clinic

Neurology | December 7, 2023 | Volume: 82 | Issue: 10_supplement | Pages: No page available

10.1212/wnl.82.10_supplement.s22.005 Get It

Tacrolimus-Induced Tremor: Switching from Immediate-Release (IR-TAC) to LCP-Tacro Extended-Release Tacrolimus (LCPT) Reduces Tremor and Improves Quality of Life (P4.072)
Morgan, John C. , Nigro, V., Mehta, Shyamal H. , Langone, Anthony J. , Sethi, Kapil D.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 82 | Issue: 10_supplement | Pages: No page available

10.1212/wnl.82.10_supplement.p4.072 Get It

Repeat Submandibular Gland Biopsies as a Progression Marker in Parkinson’s Disease (S10.002)
Adler, Charles, Hinni, Michael L., Intorcia, Anthony J., Mehta, Shyamal, Sue, Lucia I., Beach, Thomas G. , Serrano, Geidy E. , Mehta, Shyamal H. , Lott, David G.

Mayo Clinic

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.s10.002 Get It